★
Trade Filings
Managers Stocks Filings Superinvestors
Signals Institutional Buying Institutional Selling Insider Activity 13D & 13G Watch Sector Rotation
Tools Stock Screener Manager Screener Compare Managers Consensus Baskets All Research Tools Data API
Learn & AI Learn Ask the Data AI Agents
News ★ Saved
About About us Methodology Contact Disclaimer
Reader
DATA PLANS

Historical data downloads: coming with accounts.

API GATEWAY

Free read-only JSON access to the site's cached data.

Dark mode

Guided View
New to markets (prices, yields, YTD, market cap)? We explain every term as you browse, in plain English. Same data, with the help built in.

Expert View
You already know the market. Just the data: clean, fast and compact, with no extra explanations. This is the default view.

Interface language
Manager record · ✦ curated · archived quarter

Glenview Capital

Larry Robbins (CEO) · New York, NY · CIK 1138995 · EDGAR filings ↗

Healthcare-heavy fundamental manager.

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Diff ⇄
$3.57BReported 13F value
43Positions
67.7%Top-10 weight
13.70Effective holdings
13.8%Est. turnover
+10New
−12Exits

Reported 13F portfolio value covers U.S. reportable long positions only, not cash, bonds, shorts or non-U.S. holdings. It is not assets under management.

Reported value by quarter Q2 2024 → Q2 2026
Sector exposure
Healthcare 53.7% (-1.7pp)
Financial Services 12.4% (+0.4pp)
Technology 11.9% (+2.4pp)
Consumer Cyclical 10.7% (+2.3pp)
Industrials 3.7% (-1.3pp)
Consumer Defensive 3.1% (+0.0pp)
Communication Services 2.5% (+0.0pp)
Basic Materials 1.9% (-2.1pp)

Share of reported common-equity value; (±pp) vs prior quarter.

The portfolio · Q2 2025
#SecurityWeightValueSharesΔ sharesHeld
1 CVS CVS Health Corp. 16.0% $565.42M 8.20M -31.4% ▼ Trim 5
2 THC Tenet Healthcare Corporation 14.6% $515.68M 2.93M -13.7% ▼ Trim 5
3 GPN Global Payments Inc. 9.8% $345.52M 4.32M +13.8% ▲ Add 5
4 TEVA Teva Pharmaceutical… 7.5% $265.21M 15.82M +7.1% ▲ Add 5
5 GTM ZoomInfo Technologies Inc. 4.7% $165.78M 16.38M +28.1% ▲ Add 5
6 ALIGHT INC (unmapped) n/a $138.00M 24.38M n/a n/a
7 AMZN Amazon.com, Inc. 3.5% $123.49M 562.87K -24.2% ▼ Trim 5
8 CI Cigna Corporation 3.5% $122.94M 371.89K -0.6% ▼ Trim 5
9 USFD US Foods Holding Corp. 3.0% $106.19M 1.38M -22.8% ▼ Trim 5
10 DXC DXC Technology Company 2.5% $89.70M 5.87M -15.7% ▼ Trim 5
11 EXPE Expedia Group, Inc. 2.4% $85.73M 508.26K -21.6% ▼ Trim 5
12 META Meta Platforms, Inc. 2.4% $85.57M 115.93K +157.0% ▲ Add 2
13 PYPL PayPal Holdings, Inc. 2.1% $74.78M 1.01M -17.3% ▼ Trim 2
14 VTRS Viatris Inc. 2.1% $73.65M 8.25M -2.9% ▼ Trim 5
15 UHS Universal Health Services… 2.0% $70.55M 389.48K -56.1% ▼ Trim 5
16 ESI Element Solutions Inc 1.8% $63.78M 2.82M +11.2% ▲ Add 5
17 DKS DICK'S Sporting Goods, Inc. 1.6% $57.47M 290.53K New New 1
18 KNX Knight-Swift Transportation… 1.5% $51.74M 1.17M -16.7% ▼ Trim 5
19 UAL United Airlines Holdings… 1.3% $45.30M 568.86K +77.1% ▲ Add 2
20 TMO Thermo Fisher Scientific… 1.2% $40.55M 100.00K New New 1
21 WDC Western Digital Corporation 1.1% $38.43M 600.57K -23.6% ▼ Trim 4
22 BC Brunswick Corporation 1.0% $36.38M 658.50K -10.0% ▼ Trim 5
23 SGRY Surgery Partners, Inc. 1.0% $33.99M 1.53M New New 1
24 MRVL Marvell Technology, Inc. 0.9% $31.50M 407.01K +97.4% ▲ Add 2
25 JBTM JBT Marel Corporation 0.8% $29.03M 241.39K +29.3% ▲ Add 3
26 W Wayfair Inc. 0.8% $27.00M 527.89K +56.1% ▲ Add 2
27 UBER Uber Technologies, Inc. 0.7% $24.88M 266.67K -39.4% ▼ Trim 5
28 MYGN Myriad Genetics, Inc. 0.7% $24.36M 4.59M +17.6% ▲ Add 5
29 MKSI MKS Inc. 0.7% $23.08M 232.30K New New 1
30 CLVT Clarivate Plc 0.6% $20.46M 4.76M -19.1% ▼ Trim 5
31 BLCO Bausch + Lomb Corporation 0.6% $20.22M 1.55M +210.8% ▲ Add 2
32 BFLY Butterfly Network, Inc. 0.6% $20.01M 11.67M 0.0% Held 5
33 COO The Cooper Companies, Inc. 0.6% $19.97M 280.69K New New 1
34 MCK McKesson Corporation 0.5% $18.75M 25.58K -68.7% ▼ Trim 5
35 EYE National Vision Holdings… 0.5% $18.70M 812.53K New New 1
36 IQV IQVIA Holdings Inc. 0.4% $15.76M 100.00K New New 1
37 RH Rh 0.4% $12.46M 65.92K New New 1
38 DHR Danaher Corporation 0.3% $9.88M 50.00K New New 1
39 ON ON Semiconductor Corporation 0.3% $9.13M 174.19K New New 1
40 DNA Ginkgo Bioworks Holdings… 0.0% $1.68M 149.38K -20.3% ▼ Trim 5
41 SNDK Sandisk Corporation 0.0% $1.18M 26.03K -90.1% ▼ Trim 2

Common-stock (SH) positions only; option lines are in the Options tab and are never netted. ✂ = change computed against split-adjusted prior shares. “Held N+” = held every quarter in our window, possibly longer.

Position age
100–1 quarters
92–4 quarters
215–8 quarters

Consecutive quarters each current position has been reported, within our data window.

Similar managers
ManagerCommon positionsName overlapWeighted similarity
Holocene Advisors, LP 24 3.0% 0.2532 Compare ⇄
Dodge & Cox 16 6.5% 0.2039 Compare ⇄
Appaloosa 4 6.3% 0.2021 Compare ⇄
Parnassus Investments, Llc 13 7.9% 0.1892 Compare ⇄
Point72 Asset Management 32 1.7% 0.1872 Compare ⇄
Grantham, Mayo, Van Otterloo & Co. LLC 21 3.1% 0.1843 Compare ⇄
Tiger Global Management 7 8.6% 0.1769 Compare ⇄
Boston Partners 26 3.2% 0.1752 Compare ⇄

Similarity of reported longs only; hedges and non-13F assets are invisible. Methodology

Filing record
Aug 14 2026 13F-HR · period Q2 2026

$5.49B · 45 holdings listed · View original SEC filing ↗

May 15 2026 13F-HR · period Q1 2026

$3.98B · 44 holdings listed · View original SEC filing ↗

Feb 17 2026 13F-HR · period Q4 2025

$4.91B · 57 holdings listed · View original SEC filing ↗

Nov 14 2025 13F-HR · period Q3 2025

$4.49B · 54 holdings listed · View original SEC filing ↗

Aug 14 2025 13F-HR · period Q2 2025

$3.57B · 43 holdings listed · View original SEC filing ↗

May 15 2025 13F-HR · period Q1 2025

$4.07B · 45 holdings listed · View original SEC filing ↗

Feb 14 2025 13F-HR · period Q4 2024

$3.96B · 36 holdings listed · View original SEC filing ↗

Nov 14 2024 13F-HR · period Q3 2024

$5.17B · 46 holdings listed · View original SEC filing ↗

Aug 14 2024 13F-HR · period Q2 2024

$5.08B · 48 holdings listed · View original SEC filing ↗

Provenance: All holdings parsed from this manager's 13F information tables on SEC EDGAR; values as reported, whole USD. Changes compare the latest accepted version of each quarter (amendments incorporated) on split-adjusted share counts. Reporting period: Q2 2025 · latest filing Aug 14, 2026 · Change methodology